Cargando…

Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment

SIMPLE SUMMARY: Photodynamic therapy (PDT) by means of a photosensitizer is a clinically used therapeutic treatment in a variety of cancers. To further improve the anti-cancer efficiency of PDT, combination therapy with immune agents is a promising option. In this study, we used a viral vaccine as t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Yang, Gu, Zili, Yu, Zhenfeng, Schomann, Timo, Sayedipour, Sana, Aguilar, Julio C., ten Dijke, Peter, Cruz, Luis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179923/ https://www.ncbi.nlm.nih.gov/pubmed/35681703 http://dx.doi.org/10.3390/cancers14112724

Ejemplares similares

Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence
por: Hao, Yang, et al.
Publicado: (2023)

Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
por: Petrovskis, Ivars, et al.
Publicado: (2021)

Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
por: Hao, Yang, et al.
Publicado: (2022)

PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine
por: Dishlers, Andris, et al.
Publicado: (2023)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core
por: Rybka, Jakub Dalibor, et al.
Publicado: (2019)

Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy
por: Hao, Yang, et al.
Publicado: (2022)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020)

The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population
por: Hyun, Chul S., et al.
Publicado: (2019)

Cost‐effective purification process development for chimeric hepatitis B core (HBc) virus‐like particles assisted by molecular dynamic simulation
por: Zhang, Bingyang, et al.
Publicado: (2021)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
por: Pushko, Peter, et al.
Publicado: (2020)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

Peptidyl-prolyl cis/trans isomerase Pin1 interacts with hepatitis B virus core particle, but not with HBc protein, to promote HBV replication
por: Kwon, Hyeonjoong, et al.
Publicado: (2023)

Development of a vaccine delivery system using hepatitis B core antigen based VLPs to deliver mycobacterial antigens
por: Dhanasooraj, Dhananjayan, et al.
Publicado: (2012)

Beam position for the 2m HBC
por: Perreau, J M, et al.
Publicado: (1964)

Report on the future program for the HBC 200
por: CERN. Geneva. Track Chamber Committee
Publicado: (1975)

Memorandum : HBC 200 Camera Window
por: Stierlin, R G, et al.
Publicado: (1975)

Geometry titles for the 2m HBC
por: Kellner, G
Publicado: (1969)

Isolated Anti-HBc: Significance and Management
por: MORETTO, Florian, et al.
Publicado: (2020)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019)

A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles
por: González-Domínguez, Irene, et al.
Publicado: (2021)

High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout
por: Yang, Jeong In, et al.
Publicado: (2023)

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide
por: Schumacher, Jens, et al.
Publicado: (2018)

Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus than Sequential Immunization
por: Malm, Maria, et al.
Publicado: (2019)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
por: Valley-Omar, Ziyaad, et al.
Publicado: (2011)

Production of Brazilian human norovirus VLPs and comparison of purification methods
por: Lamounier, Thais Alves da Costa, et al.
Publicado: (2015)

Construction of HER2-Specific HIV-1-Based VLPs
por: Martins, Sofia A., et al.
Publicado: (2022)

T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc
por: Araujo, Patricia, et al.
Publicado: (2013)

Test on double pulsing of the 2m HBC
por: Blumenfeld, H, et al.
Publicado: (1970)

Proposals of experiments to be performed with stopping $K^{-}$ in HBC
por: Padua Bubble Chamber and Separator Group, et al.
Publicado: (1962)

Optical constant determination for the 2 meter HBC
por: Bergé, J P
Publicado: (1975)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs
por: Jourdan, N., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_caoftqtd5jmk3glh6vo8931vd3